[Clinical experiences with hexobendine in coronary disease].
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004562:Electrocardiography; D005029:Ethylenediamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000139:chemically induced; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011247:Pregnancy; D011674:Pulse / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced
D002301:Cardiac Glycosides; D005029:Ethylenediamines; D014665:Vasodilator Agents
Klinische Erfahrung mit Hexobendin bei Coronarerkrankungen.